Betterchem
Health     Drug Information     DMFs     Portal     21CFR     Search     Site Map

 
FDA Warning Letters citing this API.

 

This API's Main News Page.
 

 

FDA Approval Activities for this Drug…

ADDERALL (Mixed Salts of a Single-Entity Amphetamine Product) Tablets, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg, 20 mg and 30 mg Tablets. Shire Pharmaceutical Development NDA 11-522/S-030 11/8/02 11/19/02 10/9/03 ADDERALL CII (Mixed Salts of a Single-Entity Amphetamine Product) Tablets, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg, 20 mg and 30 mg, Shire Pharmaceutical Development NDA 11-522/S-029 4/11/02 Adderall XR Capsule, Shire NDA 21-303/S1 5/22/02 5/29/02 5/23/02 Adderall XR Capsule, Shire NDA 21-303 Adderall XR (mixed salts of a single-entity amphetamine product) Extended-Release Capsules, Shire, Patient Population Altered

For the most up-to-date approval information, please locate this API using the drug index.


 

Other APIs… A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z

Find API by Brand Name | Health | DMF Index | 21 CFR | Federal Register | Home Page | Site Map

 

 

 

© 2007 Betterchem Corp.